Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06775964 · ClinicalTrials.gov registry record · Phase 1
Stem Cell Therapy for Early Alzheimer's Disease
A Phase 1 study of Cognitive Dysfunction, sponsored by Paul E Schulz.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06775964 is a Phase 1 study of Cognitive Dysfunction that is actively recruiting participants, run by Paul E Schulz. The registered enrollment target is 12 participants, below the 1,993-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06775964, a Phase 1 study of Cognitive Dysfunction, is actively recruiting participants, sponsored by Paul E Schulz.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given back to participants, so they are their own donor. The main questions this trial aims to answer are: * Does stem cell therapy reduce inflammation in the brain? * Does stem cell therapy improve brain activity? * Does stem cell therapy slow down progression to Alzheimer's disease? Participants will: * Have a small fat biopsy taken at a doctor's office to process stem cells * Receive 4 infusions of stem cells, through a vein in the arm over 12 weeks * Visit the clinic every 2-4 weeks for the first 4 months and then every 1-2 months for 8 months for checkups and tests
Conditions Studied
Interventions
- BIOLOGICAL adMSC
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston (UTHealth) - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06775964
The ClinicalTrials.gov registry entry for NCT06775964 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,993-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (99% lower). The listed sponsor is Paul E Schulz, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which adMSC is the first listed.
NCT06775964 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06775964 about?
NCT06775964 is a clinical study titled "Stem Cell Therapy for Early Alzheimer's Disease". The goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given back to participant...
What is the current status of trial NCT06775964?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2026-02. Estimated completion is 2027-01.
What conditions does trial NCT06775964 study?
This clinical trial studies the following conditions: Cognitive Dysfunction.
What interventions are being tested in trial NCT06775964?
The interventions under investigation include: adMSC (BIOLOGICAL).
Who is sponsoring clinical trial NCT06775964?
This trial is sponsored by Paul E Schulz, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06775964 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
RECRUITING · NA
-
Surviving Daily Life
RECRUITING
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
RECRUITING · NA
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.